EpiVax Drives Immunogenicity Innovation in 2024: Year in Review

EpiVax Drives Immunogenicity Innovation in 2024: Year in Review

PROVIDENCE, R.I., Dec. 7, 2024 /PRNewswire/ -- EpiVax, Inc., a leader in preclinical immunogenicity risk assessment for biologic and peptide therapeutics, celebrates a productive 2024 marked by scientific innovation, service diversification, and...

TraceLink Honored on Inc.'s 2024 Best in Business List

TraceLink Honored on Inc.'s 2024 Best in Business List

Recognized in the Manufacturing Category for Driving Innovation and Excellence in Supply Chain Solutions BOSTON, Dec. 6, 2024 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent supply chain orchestration,...

CNEY Entered into Warrant Inducement Agreements with Certain Holders

CNEY Entered into Warrant Inducement Agreements with Certain Holders

LISHUI, China, Dec. 5, 2024 /PRNewswire/ -- CN Energy Group. Inc. (NASDAQ: CNEY) ("CNEY" or the "Company") today announced that it entered into Warrant Inducement Agreements with certain holders (each, a "Holder") of the Company's existing ordinary...

SS&C to Present at Abu Dhabi Finance Week

SS&C to Present at Abu Dhabi Finance Week

WINDSOR, Conn., Dec. 5, 2024 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC), a global provider of software and software-enabled services for the financial services and healthcare industries, today announced that Bill Stone,...

ReTo Secured Production Line Contract with Middle Eastern Client

ReTo Secured Production Line Contract with Middle Eastern Client

BEIJING, Dec. 4, 2024 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo" or the "Company"), a provider of technology solutions and operation services for intelligent ecological environments and Internet of Things technology development...

Akeso's Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Combination Therapy for PD-(L)1 Resistant NSCLC Showcased in Oral Presentation at 2024 Asian Conference on Lung Cancer

Akeso's Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Combination Therapy for PD-(L)1 Resistant NSCLC Showcased in Oral Presentation at 2024 Asian Conference on Lung Cancer

HONG KONG, Dec. 4, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the results from a prospective, open-label, single-arm, multi-center phase Ib/II clinical study (AK104-IIT-018) of cadonilimab (PD-1/CTLA-4 bispecific...

CNEY Receives NASDAQ Minimum Bid Price Requirement Extension

CNEY Receives NASDAQ Minimum Bid Price Requirement Extension

LISHUI, China, Dec. 4, 2024 /PRNewswire/ -- CN Energy Group. Inc. (NASDAQ: CNEY) ("CNEY" or the "Company") today announced that on November 26, 2024, the Company received a written notice from the Listing Qualifications Staff of The Nasdaq Stock...

Axcelis Announces Participation in SEMICON Japan 2024

Axcelis Announces Participation in SEMICON Japan 2024

BEVERLY, Mass., Dec. 3, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will showcase its Purion™ and GSD Ovation™...

Akeso to Present at Citi 2024 Global Healthcare Conference and the 7th Annual Evercore HealthCONx Conference

Akeso to Present at Citi 2024 Global Healthcare Conference and the 7th Annual Evercore HealthCONx Conference

HONG KONG, Nov. 29, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce its participation in the upcoming 7th Annual Evercore HealthCONx Conference and Citi 2024 Global Healthcare Conference, both taking...

ARLO UNVEILS ALL-NEW WIRED FLOODLIGHT CAMERA FOR ULTIMATE OUTDOOR PROTECTION IN AUSTRALIA

ARLO UNVEILS ALL-NEW WIRED FLOODLIGHT CAMERA FOR ULTIMATE OUTDOOR PROTECTION IN AUSTRALIA

Latest DIY Smart Floodlight Camera Builds on Arlo's Award-Winning Wire-Free Floodlight SINGAPORE, Nov. 28, 2024 /PRNewswire/ -- Arlo Technologies, Inc. (NYSE: ARLO), a leading smart home security brand, announced the Wired Floodlight Camera, an...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 14
  • menu
    menu